Protagonist Therapeutics
PTGX
#3740
Rank
โ‚น233.71 B
Marketcap
โ‚น3,921
Share price
11.55%
Change (1 day)
173.08%
Change (1 year)

Revenue for Protagonist Therapeutics (PTGX)

Revenue in 2024 (TTM): โ‚น26.60 Billion

According to Protagonist Therapeutics 's latest financial reports the company's current revenue (TTM ) is โ‚น26.93 Billion. In 2023 the company made a revenue of โ‚น4.99 Billion an increase over the revenue in the year 2022 that were of โ‚น2.19 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Protagonist Therapeutics from 2015 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) โ‚น26.60 B432.56%
2023 โ‚น4.99 B127.09%
2022 โ‚น2.19 B8.02%
2021 โ‚น2.03 B-2.74%
2020 โ‚น2.09 B12609.89%
2019 โ‚น16.47 M-99.24%
2018 โ‚น2.16 B68.8%
2017 โ‚น1.28 B
2016 N/A
2015 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA